From Wisconsin to New Zealand: InControl Medical Continues International Sales Expansion with InTone and Apex, the Non-Surgical, Drug Free Treatment Solutions for Female Urinary Incontinence
BROOKFIELD, Wis.–(BUSINESS WIRE)–InControl Medical, LLC,a women’s health company focusing on female urinary incontinence, introducesInTone®andApex®, the non-surgical, drug-free treatments for female urinary incontinence to women in New Zealand.According to the New Zealand Continence Association, “More than 1.1 million (25%) of New Zealanders experience bladder or bowel control problems. In total, incontinence costs our country around $8.05 billion every year. Broken down, this accounts for $7,000 per person with incontinence per year in health, loss of productivity, informal care and other costs.”
“There is significant interest to expand distribution of our devices to other countries around the globe throughout 2014.”
This is good news for the millions of women suffering from involuntary loss of urine. In addition to being an uncomfortable, personally sensitive condition, incontinence can be related to other serious health concerns, from pelvic pain to sexual dysfunction. Until now the only solution was expensive diapers or pads, taking medication or undergoing painful surgery.
InToneis a proprietary, patented women’s health device for stress, urge and mixed incontinence, utilizing a scientifically-derived muscle stimulation algorithm, active resistance and biofeedback to dramatically increase muscle strength in the pelvic floor, providing effective treatment for stress, urge and mixed female urinary incontinence.
Apexis the first-choice treatment for women with mild to moderate stress incontinence following childbirth or menopause as it makes use of a specific muscle stimulation algorithm in conjunction with a patented, customizable probe to strengthen the muscles of the pelvic floor in order to avoid leakage commonly associated with coughing, laughing, sneezing or exercising.“
I am so pleased our medical devices that solved incontinence issues for millions of women in the U.S. are now available to help countless women in New Zealand,” says Herschel Peddicord, founder and CEO ofInControl Medical. “There is significant interest to expand distribution of our devices to other countries around the globe throughout 2014.”
InControl Medical has receivedISO 13485certification from theInternational Organization for Standardization(ISO) and theCE mark of the European Commission(EC), signifying that it meets comprehensive quality management requirements in the design and manufacture of medical devices. For more information aboutInControl Medicalor InToneandApex, seehttp://www.incontrolmedical.com.
For InControl Medical
Suzy Ginsburg, 713-721-4774